Back
BioNTech SE Quote, Financials, Valuation and Earnings
![](/images/offers/ims/large/offer5.jpg)
Groundbreaking AI Developed In Small Georgia Town Destroys Wall Street
See the remarkable discovery.
Sell
36
BNTX
BioNTech SE
Last Price:
86.05
Seasonality Move:
-12.8%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer3.jpg)
Wall Street's Worst Nightmare: Small Town Trader's AI Edge
See the AI advantage for everyday Americans.BioNTech SE Price Quote
$86.05
+1.45 (+1.71%)
(Updated: July 26, 2024 at 6:55 PM ET)
BioNTech SE Key Stats
Sell
36
BioNTech SE (BNTX)
is a Sell
Day range:
$82.70 - $85.96
52-week range:
$78.02 - $125.83
Dividend yield:
0%
P/E ratio:
20.40
P/S ratio:
6.88
P/B ratio:
0.95%
Volume:
391K
Avg. volume:
640.2K
1-year change:
-20.83%
Market cap:
$20.4B
Revenue:
$4.1B
EPS:
$0.48
How Much Does BioNTech SE Make?
-
How Much Are BioNTech SE's Sales Annually?
BNTX Revenues are $4.1B -
How Much Profit Does BioNTech SE's Make A Year?
BNTX net income is $1B
Is BioNTech SE Growing As A Company?
-
What Is BioNTech SE's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.85% -
What Is BioNTech SE's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
BioNTech SE Stock Price Performance
-
Did BioNTech SE Stock Go Up Last Month?
BioNTech SE share price went up by 0.26% last month -
Did BNTX's Share Price Rise Over The Last Year?
BNTX share price fell by -20.83% over the past 1 year
What Is BioNTech SE 52-Week High & Low?
-
What Is BioNTech SE’s 52-Week High Share Price?
BioNTech SE has traded as high as $125.83 over the past 52 weeks -
What Is BioNTech SE’s 52-Week Low Share Price?
BioNTech SE has traded as low as $78.02 over the past 52 weeks
BioNTech SE Price To Free Cash Flow
-
Is BioNTech SE Stock Overvalued?
BioNTech SE is trading at a price to free cash flow ratio of 3.81 -
Is BioNTech SE Stock Undervalued?
BioNTech SE EV to Free Cash Flow ratio is 0.70 -
What Is BioNTech SE’s Price Earnings Growth Ratio?
BNTX PEG ratio is 0.00 -
Is BioNTech SE Trading At A Premium To Earnings?
BioNTech SE EV to EBIT ratio is 0.00
Is It Risky To Buy BioNTech SE?
-
How Much Debt Does BioNTech SE Have?
Total long term debt quarterly is $255.2M -
How Much Cash Does BioNTech SE Have?
Cash and short term investments quarterly total is $16.9B -
What Is BioNTech SE’s Book Value Per Share?
Book value per share is 90.71
Is BioNTech SE Cash Flow Positive?
-
What Is BNTX Cash Flow From Operations?
Cash flow from operations (TTM) is $6.2B -
What Is BioNTech SE’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$538.5M -
What Is BioNTech SE’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$9.2B
BioNTech SE Return On Invested Capital
-
Is Management Doing A Good Job?
BNTX return on invested capital is 0.54% -
What Is BioNTech SE Return On Assets?
ROA measures how assets are converting to revenues and is 0.49% -
What Is BNTX Return On Equity?
ROE is a measure of profitability and is 0.54%
BioNTech SE Earnings Date & Stock Price
-
What Is BioNTech SE's Stock Price Today?
A single share of BNTX can be purchased today for 84.60 -
What Is BioNTech SE’s Stock Symbol?
BioNTech SE trades on the nasdaq under the ticker symbol: BNTX -
When Is BioNTech SE’s Next Earnings Date?
The next quarterly earnings date for BioNTech SE is scheduled on August 5, 2024 -
When Is BNTX's next ex-dividend date?
BioNTech SE's next ex-dividend date is June 2, 2022 -
How To Buy BioNTech SE Stock?
You can buy BioNTech SE shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
BioNTech SE Competitors
-
Who Are BioNTech SE's Competitors?
Below is a list of companies who compete with BioNTech SE or are related in some way:
BioNTech SE Dividend Yield
Data Unavailable
BioNTech SE Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 2.61% |
Revenue: | -85.14% | -49.48% |
Analyst Recommendations
Buy Recommendations: | 4 |
---|---|
Hold Recommendations: | 9 |
Sell Recommendations: | 1 |
Price Target: | 111.90 |
Upside from Last Price: | 32.26% |